Andrew Koren
Overview
Explore the profile of Andrew Koren including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
302
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pokorney S, Nemeth H, Chiswell K, Albert C, Allyn N, Blanco R, et al.
Am Heart J
. 2024 Oct;
279:66-75.
PMID: 39423993
Background: While there are several completed clinical trials that address treatment strategies in patients with symptomatic and recurrent atrial fibrillation (AF), there are no randomized clinical trials that address first-line...
2.
Wharton J, Piccini J, Koren A, Huse S, Ronk C
J Am Heart Assoc
. 2022 Jan;
11(3):e020506.
PMID: 35060388
Background Atrial tachyarrhythmias are common after atrial fibrillation ablation, so adjunctive antiarrhythmic drug therapy is often used. Data on the effectiveness and safety of dronedarone and sotalol after AF ablation...
3.
Mahmood T, Minnier J, Ito M, Li Q, Koren A, Kam I, et al.
Eur J Prev Cardiol
. 2021 Jul;
28(8):816-822.
PMID: 34298554
Aims: Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors consistently reduce low-density lipoprotein cholesterol (LDL-C) by 50-60% and lipoprotein(a) (Lp(a)) by 20-30%, but the mechanism of Lp(a) lowering remains unclear. If...
4.
Bassetti M, Echols R, Koren A, Karas A, Longshaw C, Yamano Y, et al.
Lancet Infect Dis
. 2021 Jun;
21(7):908-909.
PMID: 34174228
No abstract available.
5.
Koren A, Karas A, Echols R
Clin Drug Investig
. 2021 May;
41(7):659-660.
PMID: 34037974
No abstract available.
6.
Tardos J, Ronk C, Patel M, Koren A, Kim M
J Am Heart Assoc
. 2021 Mar;
10(6):e016792.
PMID: 33686868
Background Current American Heart Association/American College of Cardiology/Heart Rhythm Society guidelines and European Society of Cardiology guidelines recommend antiarrhythmic drugs (AADs) for maintenance of sinus rhythm in patients with atrial...
7.
Blomstrom-Lundqvist C, Marrouche N, Connolly S, Corp Dit Genti V, Wieloch M, Koren A, et al.
Clin Cardiol
. 2020 Oct;
43(12):1469-1477.
PMID: 33080088
Background: Atrial fibrillation/atrial flutter (AF/AFL) burden increases with increasing duration of AF/AFL history. Hypothesis: Outcomes with dronedarone may also be impacted by duration of AF/AFL history. Methods: In this post...
8.
Ha A, Stewart J, Klein G, Roy D, Connolly S, Koren A, et al.
Am Heart J
. 2020 Jun;
226:152-160.
PMID: 32580074
Objective: We examined the effect of ECV and rhythm status on QoL of patients with symptomatic persistent AF in a randomized controlled trial. Method: The elective cardioversion for prevention of...
9.
Lowenstern A, Li S, Virani S, Navar A, Li Z, Robinson J, et al.
Am Heart J
. 2020 Jun;
225:88-96.
PMID: 32485329
Methods: We performed an observational study of 7628 patients with (n = 2943) and without DM (n = 4685), enrolled in the Provider Assessment of Lipid Management (PALM) registry and...
10.
Thind M, Crijns H, Naccarelli G, Reiffel J, Corp Dit Genti V, Wieloch M, et al.
J Cardiovasc Electrophysiol
. 2020 Feb;
31(5):1022-1030.
PMID: 32083368
Introduction: The phase 3 EURIDIS and ADONIS studies evaluated dronedarone for atrial fibrillation (AF)/atrial flutter (AFL) recurrence in patients with nonpermanent AF. Here we assessed whether patient characteristics and/or treatment...